WO2025063255A1 - アンモニアリアーゼおよびその用途 - Google Patents
アンモニアリアーゼおよびその用途 Download PDFInfo
- Publication number
- WO2025063255A1 WO2025063255A1 PCT/JP2024/033555 JP2024033555W WO2025063255A1 WO 2025063255 A1 WO2025063255 A1 WO 2025063255A1 JP 2024033555 W JP2024033555 W JP 2024033555W WO 2025063255 A1 WO2025063255 A1 WO 2025063255A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- ammonia lyase
- present
- lyase activity
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Definitions
- the present invention relates to an ammonia lyase and its uses.
- Ammonia lyase is known to originate from a variety of organisms.
- Non-Patent Document 1 aromatic ammonia lyases in plants include enzymes that act only on phenylalanine (Phe) or on both Phe and tyrosine (Tyr), but there have been no reports of ammonia lyases for histidine (His) (although there have been reports in animals and microorganisms). Furthermore, no ammonia lyases that act only on Tyr have been found in plants. Furthermore, Non-Patent Document 1 discloses that the specificity of each enzyme involves amino acid residues at positions 148, 276, 405, 415, and 453, and also discloses that the three-dimensional structures have been analyzed and the types of amino acids involved in each substrate have been identified.
- Non-Patent Document 2 analyzes the three-dimensional structure of plant-derived Phe ammonia-lyase and discloses that the activity is affected by the 89th and 90th amino acids due to the alignment of related amino acids. The document also discloses that His, Phe, and Cys (cysteine) are present at position 89, and Leu (leucine), Glu (glutamic acid), and His are present at position 90, and that many other conserved sequences are also present.
- Non-patent document 3 is a document about the TAL enzyme, which was discovered for the first time in a microorganism. According to this document, it is known that Rhodobacter capsulatus produces a substance called photoactive yellow protein, and it was speculated that TAL enzymes are involved in its biosynthesis. The document then discovered a gene sequence that shared 32% homology with PAL estimated from the genome sequence, and disclosed that this sequence was introduced into Escherichia coli, where it was expressed and the enzyme activity was compared. As a result, activity against Tyr was confirmed, and slight activity was also observed against Phe.
- Non-patent literature 4 discloses that 46 sequences presumed to be TAL enzyme genes were selected from genes registered in BLAST, and expressed in Escherichia coli, and the activity of five TAL enzymes was successfully measured.
- the document discloses that the TAL enzyme derived from Chryseobacterium luteum sp nov in particular was highly active, producing 2.03 g/L of coumaric acid in an 8-hour reaction, and that the TAL enzyme derived from Rivularia sp PCC7116 produced 2.35 g/L of coumaric acid in a 24-hour reaction, and also acted slightly on Phe.
- One object of the present invention is to provide an ammonia lyase and its uses.
- a protein comprising an amino acid sequence having 80% or more sequence homology to the amino acid sequence represented by SEQ ID NO:1 and having ammonia lyase activity.
- the ammonia lyase activity is preferably at least one activity selected from the group consisting of 4-aminophenylalanine-ammonia lyase activity, tyrosine-ammonia lyase activity, histidine-ammonia lyase activity, and phenylalanine-ammonia lyase activity.
- nucleic acid encoding the above protein
- vector comprising the nucleic acid
- cell comprising the nucleic acid or vector in an expressible manner
- a method for producing 4-aminocinnamic acid (4-ACA) comprising a step of carrying out an enzymatic reaction by the protein of the present invention using 4-aminophenylalanine as a substrate.
- a method for producing p-coumaric acid comprising a step of carrying out an enzymatic reaction by the protein of the present invention using tyrosine as a substrate.
- a method for producing 4-imidazole-acrylic acid comprising a step of carrying out an enzymatic reaction by the protein of the present invention using histidine as a substrate.
- a method for producing cinnamic acid comprising a step of carrying out an enzymatic reaction by the protein of the present invention using phenylalanine as a substrate.
- the present invention provides an ammonia lyase and its uses.
- Fig. 1 is a diagram (chromatogram) showing the production of 4-aminocinnamic acid (4-ACA) when an enzyme reaction is carried out using 4-aminophenylalanine as a substrate. From the top, the reaction solution before the reaction, a solution containing E. coli cells and 4-aminocinnamic acid, the reaction solution after 8 hours of reaction, and the reaction solution after 3 hours of reaction are shown. In the reaction solution before the reaction, a peak of 4-aminophenylalanine, which is the substrate, was observed. The peak of 4-aminocinnamic acid was larger after 8 hours of reaction than after 3 hours of reaction.
- FIG. 2 is a chromatogram showing the production of 4-imidazole-acrylic acid when an enzyme reaction is carried out using histidine as a substrate.
- the present invention provides a protein having ammonia lyase activity.
- This ammonia lyase makes it possible to efficiently produce 4-aminocinnamic acid (4-ACA).
- This ammonia lyase can also be used to efficiently produce p-coumaric acid.
- This ammonia lyase can also be used to efficiently produce 4-imidazole-acrylic acid.
- This ammonia lyase can also be used to efficiently produce cinnamic acid.
- the protein of the present invention is a protein that comprises an amino acid sequence that has 80% or more, preferably 90% or more, sequence homology to the amino acid sequence represented by SEQ ID NO:1, and has ammonia lyase activity.
- the ammonia lyase activity is preferably at least one activity selected from the group consisting of 4-aminophenylalanine-ammonia lyase activity, tyrosine-ammonia lyase activity, histidine-ammonia lyase activity, and phenylalanine-ammonia lyase activity.
- SEQ ID NO:1 is the amino acid sequence of a protein (PcHAL3) derived from Pseudomonas chlororaphis.
- the nucleotide sequence encoding this amino acid sequence is shown in SEQ ID NO:2.
- the present invention encompasses not only PcHAL3 having the amino acid sequence shown in SEQ ID NO:1, but also proteins that contain an amino acid sequence having 80% or more, preferably 90% or more, sequence homology to the amino acid sequence shown in SEQ ID NO:1 and have at least one of the activities exhibited by PcHAL3.
- 4-aminophenylalanine-ammonia-lyase activity is the activity that produces 4-aminocinnamic acid (4-ACA) using 4-aminophenylalanine as a substrate.
- Tyrosine-ammonia-lyase activity is the activity that produces p-coumaric acid using tyrosine as a substrate.
- Histidine-ammonia-lyase activity is the activity that produces 4-imidazole-acrylic acid using histidine as a substrate.
- Phenylalanine-ammonia-lyase activity is the activity that produces cinnamic acid using phenylalanine as a substrate.
- the protein of the present invention has ammonia lyase activity. According to another embodiment of the present invention, the protein of the present invention has 4-aminophenylalanine ammonia lyase activity. According to another embodiment of the present invention, the protein of the present invention has tyrosine ammonia lyase activity. According to another embodiment of the present invention, the protein of the present invention has histidine ammonia lyase activity. According to another embodiment of the present invention, the protein of the present invention has phenylalanine ammonia lyase activity.
- the protein of the present invention has 4-aminophenylalanine ammonia-lyase activity and tyrosine ammonia-lyase activity, and more preferably has 4-aminophenylalanine ammonia-lyase activity, tyrosine ammonia-lyase activity, histidine ammonia-lyase activity and phenylalanine ammonia-lyase activity.
- the residue corresponding to the 90th residue in SEQ ID NO:1 in the amino acid sequence of the protein of the present invention is a phenylalanine (F) residue.
- the residue corresponding to the 90th residue in SEQ ID NO:1 in the amino acid sequence of the protein of the present invention is a phenylalanine (F) residue, and the residue corresponding to the 91st residue in SEQ ID NO:1 is a histidine (H) residue.
- the protein of the present invention comprises an amino acid sequence having sequence homology of 80% or more, preferably 85% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, even more preferably 99% or more to the amino acid sequence represented by SEQ ID NO: 1.
- sequence homology of the amino acid sequence can be determined using an algorithm known in the art, such as BLASTP, with default settings.
- the protein of the present invention comprises the amino acid sequence represented by SEQ ID NO:1.
- the nucleic acid of the present invention encodes the protein of the present invention (its amino acid sequence).
- the type of nucleic acid is not particularly limited and may be any of DNA, RNA, or a combination thereof, but is preferably DNA.
- the nucleic acid of the present invention is not particularly limited in its specific nucleotide sequence as long as it encodes the protein of the present invention (its amino acid sequence), but may, for example, include a nucleotide sequence represented by SEQ ID NO: 2, or include a nucleotide sequence having sequence homology of 80% or more, preferably 85% or more, preferably 90% or more, more preferably 95% or more, even more preferably 96% or more, even more preferably 97% or more, even more preferably 98% or more, even more preferably 99% or more to the nucleotide sequence represented by SEQ ID NO: 2.
- sequence homology of the nucleotide sequence can be specified with default settings using an algorithm known in the art, such as BLASTN.
- the nucleic acid of the present invention can also be introduced into a host cell and expressed in the cell, in which case it may be designed to include many preferred codons depending on the type of host cell.
- the vector of the present invention includes the nucleic acid of the present invention.
- a vector is a plasmid for introducing an expression nucleic acid construct such as a gene into a host cell, and various types are known depending on the type of host cell used. In the present invention, an appropriate vector may be selected depending on the type of host cell used.
- the nucleic acid of the present invention may also be incorporated into a vector so as to be expressible in the host cell, and can be appropriately carried out by a person skilled in the art.
- the vector when the host cell is a prokaryote such as a bacterium, can be one that is capable of autonomous replication in the host cell or can be incorporated into a chromosome and contains a promoter at a position where the inserted nucleic acid can be transcribed.
- the vector can be used to construct a series of components consisting of a promoter, a ribosome binding sequence, the gene, and a transcription termination sequence in the host cell.
- the cell of the present invention is a cell that contains the nucleic acid of the present invention or the vector of the present invention in an expressible manner. Such a cell can be produced using a vector constructed as described above, depending on the type of cell used.
- the type of cell is not particularly limited, and may be either a prokaryotic cell or a eukaryotic cell.
- prokaryotic cells include bacteria and actinomycetes.
- eukaryotic cells include yeast, filamentous fungi, eukaryotic microalgae, plant cells, and animal cells.
- the cells used in the present invention are preferably bacteria or yeast, more preferably bacteria, and even more preferably Escherichia coli.
- a method for producing a useful substance using the protein of the present invention comprising a step of carrying out an enzymatic reaction with the protein of the present invention using 4-aminophenylalanine as a substrate; (ii) a method for producing p-coumaric acid, comprising a step of carrying out an enzymatic reaction with the protein of the present invention using tyrosine as a substrate; (iii) a method for producing 4-imidazole-acrylic acid, the method comprising a step of carrying out an enzymatic reaction with the protein of the present invention using histidine as a substrate; and (iv) There is provided a method for producing cinnamic acid, which comprises a step of carrying out an enzymatic reaction using the protein of the present invention with phenylalanine as a substrate.
- the above enzyme reaction can be carried out by a method known to those skilled in the art.
- the enzyme reaction can be carried out by adding a substrate to a medium when culturing cells (e.g., bacteria) expressing the protein of the present invention, or by adding cells expressing the protein of the present invention or a lysate of said cells to a substrate solution, or by adding an isolated protein of the present invention to a substrate solution, or by contacting a substrate solution with a support (such as a column) on which an isolated protein of the present invention is immobilized.
- a support such as a column
- the temperature and pH conditions at that time can be determined with reference to the optimum temperature and optimum pH of the enzyme of the protein used, or with reference to the temperature and pH suitable for culturing the expressing cells (e.g., bacteria).
- the protein of the present invention used in the enzyme reaction is supplied by the cells of the present invention.
- the above protein (PcHAL3) was biosynthesized by recombinant expression in a host cell, and its ammonia lyase activity was examined. Escherichea coli was used as the host cell.
- Reagent 4-Amino Phenylalanine; 4-Amino Cinnamic Acid; Histidine; 4-Imidazoleacrylic Acid.
- Reaction solution 10 mM 4APhe (100 mM Tris-HCl buffer pH 8.6) (substrate solution) 10 mM His (100 mM Tris-HCl buffer pH8.6) (substrate solution)
- E. coli was concentrated with Tris-HCl to an OD600 of 10 (specifically, the culture medium in which E. coli was cultured had an OD600 of about 2-3, and the culture medium was centrifuged to precipitate the bacteria, and Tris-HCl was added to the medium so that the final OD600 was 10).
- Reaction conditions The reaction was carried out at 37°C for 3-8 hours using a reaction solution prepared by adding the above-mentioned E. coli cells expressing PcHAL3 to a substrate solution of 10 mM 4APhe or 10 mM His. (When histidine was used as the substrate, the reaction was carried out for 3 hours, and when 4-aminophenylalanine was used as the substrate, the reaction was carried out twice, with reaction times of 3 and 8 hours, respectively.) Stirring speed: 450 rpm Sample preparation: Remove bacteria by centrifugation and measure the supernatant. HPLC: Column: C18 (4.6 x 150mm/4.6 x 250mm). Mobile phase: A: 20 mM potassium phosphate buffer; B: Methanol.
- Reagent Phenylalanine; Cinnamic Acid; Tyrosine; p-Coumaric Acid.
- Reaction solution 10 mM phenylalanine (100 mM Tris-HCl buffer pH 8.5) (substrate solution) 1 mM tyrosine (70 mM sodium pyrophosphate buffer, pH 9.3) (substrate solution)
- the E. coli was concentrated with buffer to an OD600 of 10.
- Reaction conditions The reaction was carried out at 37° C. for 1 hour using a reaction solution prepared by adding the above-mentioned E.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025547453A JPWO2025063255A1 (cg-RX-API-DMAC7.html) | 2023-09-19 | 2024-09-19 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023-151690 | 2023-09-19 | ||
| JP2023151690 | 2023-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2025063255A1 true WO2025063255A1 (ja) | 2025-03-27 |
Family
ID=95073112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2024/033555 Ceased WO2025063255A1 (ja) | 2023-09-19 | 2024-09-19 | アンモニアリアーゼおよびその用途 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2025063255A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202519654A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2025063255A1 (cg-RX-API-DMAC7.html) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014117272A (ja) * | 2012-12-19 | 2014-06-30 | Kobe Univ | クマル酸の製造方法 |
| JP2016516428A (ja) * | 2013-04-18 | 2016-06-09 | コデクシス, インコーポレイテッド | 操作されたフェニルアラニンアンモニアリアーゼポリペプチド |
| US20170166936A1 (en) * | 2014-07-14 | 2017-06-15 | Danmarks Tekniske Universitet | Processes for the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia lyase activity |
| JP2018516080A (ja) * | 2015-05-28 | 2018-06-21 | エヴォルヴァ エスアー.Evolva Sa. | フェニルプロパノイドおよびフェニルプロパノイド誘導体の生合成 |
-
2024
- 2024-09-19 JP JP2025547453A patent/JPWO2025063255A1/ja active Pending
- 2024-09-19 WO PCT/JP2024/033555 patent/WO2025063255A1/ja not_active Ceased
- 2024-09-19 TW TW113135488A patent/TW202519654A/zh unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014117272A (ja) * | 2012-12-19 | 2014-06-30 | Kobe Univ | クマル酸の製造方法 |
| JP2016516428A (ja) * | 2013-04-18 | 2016-06-09 | コデクシス, インコーポレイテッド | 操作されたフェニルアラニンアンモニアリアーゼポリペプチド |
| US20170166936A1 (en) * | 2014-07-14 | 2017-06-15 | Danmarks Tekniske Universitet | Processes for the production of hydroxycinnamic acids using polypeptides having tyrosine ammonia lyase activity |
| JP2018516080A (ja) * | 2015-05-28 | 2018-06-21 | エヴォルヴァ エスアー.Evolva Sa. | フェニルプロパノイドおよびフェニルプロパノイド誘導体の生合成 |
Non-Patent Citations (3)
| Title |
|---|
| BRACK YANNIK, SUN CHENGHAI, YI DONG, BORNSCHEUER UWE T.: "Discovery of Novel Tyrosine Ammonia Lyases for the Enzymatic Synthesis of p ‐Coumaric Acid", CHEMBIOCHEM, vol. 23, no. 10, 18 May 2022 (2022-05-18), US, pages e2022000 - e2022000-7, XP093293189, ISSN: 1439-4227, DOI: 10.1002/cbic.202200062 * |
| DATABASE GenBank 14 April 2021 (2021-04-14), "aromatic amino acid lyase [Pseudomonas chlororaphis]", XP093293194, Database accession no. MBP5061072 * |
| DATABASE GenBank 31 July 2014 (2014-07-31), "histidine ammonia-lyase [Pseudomonas chlororaphis]", XP093293191, Database accession no. AIC17634 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2025063255A1 (cg-RX-API-DMAC7.html) | 2025-03-27 |
| TW202519654A (zh) | 2025-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11261219B2 (en) | Proteolytic inactivation of select proteins in bacterial extracts for improved expression | |
| AU2017385151B2 (en) | Gene which encodes alanyl-glutamine dipeptide biosynthetic enzyme and application thereof | |
| JP2021531749A (ja) | 操作されたフェニルアラニンアンモニアリアーゼポリペプチド | |
| CN116287050A (zh) | 亚胺还原酶、突变体及其在四氢-β-咔啉类衍生物合成中的应用 | |
| CN107858384B (zh) | 一种利用活性包涵体制备光学纯l-叔亮氨酸的方法 | |
| Chen et al. | A novel molecular chaperone GroEL2 from Rhodococcus ruber and its fusion chimera with nitrile hydratase for co-enhanced activity and stability | |
| CN108998462B (zh) | 含锰离子重组蛋白的大肠杆菌表达系统及其应用方法 | |
| CN116855467A (zh) | 一种化学-酶偶联方法用于合成麦角硫因 | |
| CN112522228B (zh) | 一种来源于氨氧化假诺卡氏单胞菌的r-转氨酶及其合成方法 | |
| CN111051508A (zh) | D型氨基酸脱氢酶 | |
| CN109402188B (zh) | 一种来自短小芽孢杆菌的ω-转氨酶及在生物胺化中的应用 | |
| CN107109446A (zh) | 顺式‑5‑羟基‑l‑哌可酸的制造方法 | |
| CN111133105B (zh) | D型氨基酸脱氢酶 | |
| TW202519654A (zh) | 解氨酶及其用途 | |
| CN117965514A (zh) | 芳香族氨基酸解氨酶突变体及其制备反式肉桂酸和对香豆酸的方法 | |
| CN111117979B (zh) | 转氨酶突变体、酶制剂、重组载体、重组细胞及其制备方法和应用 | |
| CN117730147A (zh) | 苯丙素类化合物的生物合成 | |
| KR20190002239A (ko) | 오르니틴 탈탄산 효소의 변이주 개발 방법 및 그의 응용 | |
| CN107988281B (zh) | Aro8在催化生产l-蛋氨酸中的用途 | |
| JP2021003034A (ja) | Efpタンパク質を発現する大腸菌およびそれを用いたフラボノイド化合物製造方法 | |
| KR101071274B1 (ko) | 미생물 유래의 사슬형 트랜스아미나제를 이용한 L-6-hydroxynorleucine의 생산방법 | |
| CN101724673B (zh) | 一种制备甲基万古霉素的方法 | |
| JP2015139426A (ja) | 新規β−アミノ酸の製造方法 | |
| CN107630053A (zh) | 一种生产β‑丙氨酸的方法及其专用工程菌 | |
| JP2003219892A (ja) | 耐熱性システイン合成酵素 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24868332 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2025547453 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2025547453 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |